Copyright
©The Author(s) 2025.
World J Stem Cells. Mar 26, 2025; 17(3): 103560
Published online Mar 26, 2025. doi: 10.4252/wjsc.v17.i3.103560
Published online Mar 26, 2025. doi: 10.4252/wjsc.v17.i3.103560
Table 1 Applications of exosomes from different sources in various diseases
Source cell | Disease | Effect | Year | Ref. |
Bone marrow mesenchymal stromal cells | Acute kidney injury | Promote renal tubular epithelial cell regeneration | 2017 | [42] |
Mesenchymal stem cells | Ischemic myocardium | Cardioprotection | 2015 | [43] |
Bone marrow mesenchymal stromal/stem cell | Acute graft-versus-host disease | Prolonged the survival of acute graft-versus-host disease mice and reduced pathological damage in multiple graft-versus-host disease target organs | 2018 | [52] |
Tumor | Colorectal cancer | Promote liver metastasis | 2020 | [53] |
Mesenchymal stromal cells | Myocardial ischaemia-reperfusion | Attenuate myocardial ischaemia-reperfusion injury | 2019 | [54] |
Bone marrow mesenchymal stem cells | Acute lung injury | Ameliorate LPS-induced acute lung injury | 2024 | [56] |
M1 macrophages | Tumor | Enhance antitumor immunity to inhibit tumor growth | 2021 | [57] |
Mesenchymal stem cells | Multiple sclerosis | Reduce demyelination, decrease neuroinflammation, and increase the number of regulatory T cells in the spinal cord of EAE mice | 2019 | [63] |
Mesenchymal stem cells | Acquired aplastic anemia | Play a key role in immune dysregulation | 2023 | [65] |
Hypoxic mesenchymal stem cells | Bone fracture | Promote bone fracture healing | 2020 | [66] |
Mesenchymal stem cells | Osteochondral defects | Mediate cartilage repair | 2018 | [67] |
Mesenchymal stem cells | Temporomandibular joint osteoarthritis | Alleviate temporomandibular joint osteoarthritis | 2019 | [69] |
Bone marrow mesenchymal stem cells | Ulcerative colitis | Alleviate ulcerative colitis | 2019 | [74] |
Mesenchymal stem cells | Ischemia/reperfusion injury | Alleviate ischemia/reperfusion injury | 2019 | [78] |
Mesenchymal stromal cells | Pulmonary fibrosis | Alleviated the core features of pulmonary fibrosis and lung inflammation | 2019 | [79] |
Umbilical cord mesenchymal stem cells | Nerve injury-induced pain | Possess anti-inflammatory and neurotrophic abilities | 2019 | [80] |
Mesenchymal stem cells | Intrauterine adhesion | Modify intrauterine adhesion | 2022 | [81] |
Bone marrow-derived mesenchymal stem cells | Prostate cancer | Restrained prostate cancer | 2022 | [89] |
Wharton jelly-derived mesenchymal stem cells | Cervical cancer | As drug delivery systems for cervical cancer | 2022 | [90] |
Olfactory ecto-mesenchymal stem cells | Murine Sjögren’s syndrome | Ameliorate murine Sjögren’s syndrome | 2021 | [96] |
Mesenchymal stem cells | Autoimmune uveoretinitis | Inhibit activation of antigen-presenting cells and suppress development of T helper 1 and 17 cells | 2017 | [97] |
Mesenchymal stem cells | Islet transplantation | Improve islet transplantation | 2016 | [103] |
Dendritic cells | Liver transplantation | Negatively regulate CD8+ T cells via inhibition of NLRP3 | 2022 | [104] |
Endothelial cells | ARDS | Modulate the therapeutic efficacy of mesenchymal stem cells through IDH2/TET pathway in ARDS | 2024 | [107] |
- Citation: Yi YF, Fan ZQ, Liu C, Ding YT, Chen Y, Wen J, Jian XH, Li YF. Immunomodulatory effects and clinical application of exosomes derived from mesenchymal stem cells. World J Stem Cells 2025; 17(3): 103560
- URL: https://www.wjgnet.com/1948-0210/full/v17/i3/103560.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i3.103560